RecallDepth
Class II Ongoing

Lorazepam Tablets, USP, 0.5mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drug product contained in this package is from NDC # 69315-904 Leading Pharma, LLC., Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 26268 USA, NDC: 0904-6007-61

This recall is currently active, issued February 26, 2025. It was issued by The Harvard Drug Group Llc Dba Major Pharmaceuticals And Rugby Laboratories.

Company
The Harvard Drug Group Llc Dba Major Pharmaceuticals And Rugby Laboratories
Recall Initiated
January 21, 2025
Posted
February 26, 2025
Recall Number
D-0226-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
82,281 cartons
Firm Location
La Vergne, TN, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities.

Distribution

Nationwide U.S. and Puerto rico

Lot / Code Info

Lot #s: N01424, N01425, Exp 03/31/2025; N01659, N01660, Exp 08/31/2025; N01668, 09/2025; N01679, N01704, N01745, Exp 10/31/2025; N01856, Exp 02/28/2026; N01973, Exp 05/31/2026; N02079, Exp 08/31/2026.

More recalls by The Harvard Drug Group Llc Dba Major Pharmaceuticals And Rugby Laboratories

View all recalls by this company →

Other recent Class II Drug recalls